Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer (Q73836223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

title

Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

F Saint

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

J Irani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

J J Patard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

L Salomon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

A Hoznek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

S Zammattio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

H Debois

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

C C Abbou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

D K Chopin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

883-888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Intravesical Bacillus Calmette-Guérin prophylactic treatment for superficial bladder tumors: results of a controlled prospective study

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Practical approaches to the prevention and treatment of adverse reactions to BCG.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

A 12 versus 6-week course of bacillus Calmette-Guerin prophylaxis for the treatment of high risk superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Prognostic Factors in Patients Treated with Intravesical Bacillus Calmette-Guerin for Superficial Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(00)01117-1

7 January 2021

10.1016/S0090-4295(00)01117-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337287 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference